Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-14-051710
Filing Date
2014-08-20
Accepted
2014-08-20 17:21:29
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 3 v387416_sc13da.htm SC 13D/A 76612
  Complete submission text file 0001144204-14-051710.txt   78136
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Subject) CIK: 0001070336 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82163 | Film No.: 141055671
SIC: 2834 Pharmaceutical Preparations

Mailing Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 1200 BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13D/A